Cite
Impact of contrast-enhanced CT in the dosimetry of SBRT for liver metastases treated with MR-Linac
MLA
Min Liu, et al. “Impact of Contrast-Enhanced CT in the Dosimetry of SBRT for Liver Metastases Treated with MR-Linac.” Radiation Oncology, vol. 19, no. 1, Oct. 2024, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s13014-024-02533-3.
APA
Min Liu, Mingzhe Liu, Feng Yang, Yanhua Liu, Shoulong Wang, Yazhen Chen, Jie Li, Xianliang Wang, & Lucia Clara Orlandini. (2024). Impact of contrast-enhanced CT in the dosimetry of SBRT for liver metastases treated with MR-Linac. Radiation Oncology, 19(1), 1–10. https://doi.org/10.1186/s13014-024-02533-3
Chicago
Min Liu, Mingzhe Liu, Feng Yang, Yanhua Liu, Shoulong Wang, Yazhen Chen, Jie Li, Xianliang Wang, and Lucia Clara Orlandini. 2024. “Impact of Contrast-Enhanced CT in the Dosimetry of SBRT for Liver Metastases Treated with MR-Linac.” Radiation Oncology 19 (1): 1–10. doi:10.1186/s13014-024-02533-3.